as 10-29-2025 9:33am EST
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Upcoming Earnings Alert:
Get ready for potential market movements as Option Care Health Inc. OPCH prepares to release earnings report on 30 Oct 2025.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BANNOCKBURN |
| Market Cap: | 4.4B | IPO Year: | N/A |
| Target Price: | $35.33 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.26 | EPS Growth: | 5.29 |
| 52 Week Low/High: | $21.39 - $35.53 | Next Earning Date: | 10-30-2025 |
| Revenue: | $5,374,021,000 | Revenue Growth: | 17.07% |
| Revenue Growth (this year): | 14.8% | Revenue Growth (next year): | 8.56% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wright Norman L. | OPCH | Director | Sep 9 '25 | Buy | $29.31 | 3,411 | $99,976.07 | 15,501 | |
| GOLDING DAVID W | OPCH | N/A | Aug 21 '25 | Buy | $27.63 | 1,000 | $27,625.00 | 116,525 | |
| SULLIVAN TIMOTHY P | OPCH | N/A | Aug 21 '25 | Buy | $27.51 | 20,000 | $550,200.00 | 49,229 | |
| KRAEMER HARRY M JANSEN JR | OPCH | N/A | Aug 20 '25 | Buy | $27.15 | 36,000 | $977,277.60 | 375,390 | |
| Pate R Carter | OPCH | N/A | Aug 20 '25 | Buy | $27.19 | 750 | $20,391.45 | 41,910 |
OPCH Breaking Stock News: Dive into OPCH Ticker-Specific Updates for Smart Investing
Argus Research
8 days ago
Argus Research
9 days ago
StockStory
12 days ago
The Fly
12 days ago
MT Newswires
12 days ago
Argus Research
23 days ago
MT Newswires
a month ago
Argus Research
a month ago
The information presented on this page, "OPCH Option Care Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.